Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications
Frédéric Torossian, Bernadette Guerton, Adrienne Anginot, Kylie A. Alexander, Christophe Desterke, Sabrina Soave, Hsu-Wen Tseng, Nassim Arouche, Laetitia Boutin, Irina Kulina, Marjorie Salga, Beulah Jose, Allison R. Pettit, Denis Clay, Nathalie Rochet, Erica Vlachos, Guillaume Genet, Charlotte Debaud, Philippe Denormandie, François Genet, Natalie A. Sims, Sébastien Banzet, Jean-Pierre Levesque, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès
Frédéric Torossian, Bernadette Guerton, Adrienne Anginot, Kylie A. Alexander, Christophe Desterke, Sabrina Soave, Hsu-Wen Tseng, Nassim Arouche, Laetitia Boutin, Irina Kulina, Marjorie Salga, Beulah Jose, Allison R. Pettit, Denis Clay, Nathalie Rochet, Erica Vlachos, Guillaume Genet, Charlotte Debaud, Philippe Denormandie, François Genet, Natalie A. Sims, Sébastien Banzet, Jean-Pierre Levesque, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès
View: Text | PDF
Research Article Bone biology Hematology

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications

  • Text
  • PDF
Abstract

Neurogenic heterotopic ossification (NHO) is the formation of ectopic bone generally in muscles surrounding joints following spinal cord or brain injury. We investigated the mechanisms of NHO formation in 64 patients and a mouse model of spinal cord injury–induced NHO. We show that marrow from human NHOs contains hematopoietic stem cell (HSC) niches, in which mesenchymal stromal cells (MSCs) and endothelial cells provide an environment supporting HSC maintenance, proliferation, and differentiation. The transcriptomic signature of MSCs from NHOs shows a neuronal imprinting associated with a molecular network required for HSC support. We demonstrate that oncostatin M (OSM) produced by activated macrophages promotes osteoblastic differentiation and mineralization of human muscle-derived stromal cells surrounding NHOs. The key role of OSM was confirmed using an experimental model of NHO in mice defective for the OSM receptor (OSMR). Our results provide strong evidence that macrophages contribute to NHO formation through the osteogenic action of OSM on muscle cells within an inflammatory context and suggest that OSM/OSMR could be a suitable therapeutic target. Altogether, the evidence of HSCs in ectopic bones growing at the expense of soft tissue in spinal cord/brain-injured patients indicates that inflammation and muscle contribute to HSC regulation by the brain-bone-blood triad.

Authors

Frédéric Torossian, Bernadette Guerton, Adrienne Anginot, Kylie A. Alexander, Christophe Desterke, Sabrina Soave, Hsu-Wen Tseng, Nassim Arouche, Laetitia Boutin, Irina Kulina, Marjorie Salga, Beulah Jose, Allison R. Pettit, Denis Clay, Nathalie Rochet, Erica Vlachos, Guillaume Genet, Charlotte Debaud, Philippe Denormandie, François Genet, Natalie A. Sims, Sébastien Banzet, Jean-Pierre Levesque, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès

×

Figure 9

Deletion of the Osmr gene reduces NHO following SCI in mice.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of the Osmr gene reduces NHO following SCI in mice.
(A) μCT ana...
(A) μCT analysis of neurogenic heterotopic ossification (NHO) development 7–14 days following spinal cord injury (SCI) and intramuscular cardiotoxin (CDTX) injection in oncostatin M receptor null (Osmr–/–) mice compared with wild-type C57BL/6 control mice. Each dot represents an individual mouse, and the box-and-whisker plot shows median, 25th and 75 percentile, and minimum and maximum values. Statistical significance was confirmed using a Mann-Whitney test (P = 0.0038, 16 mice/group, experiment repeated twice). (B) Representative 3D reconstructed images of NHO in C57BL/6 and Osmr–/– mice 7 days after surgery. (C) Recombinant mouse oncostatin M (OSM) enhances in vitro osteogenic differentiation. Muscle interstitial cells, satellite cells, and bone marrow mesenchymal stromal cells (BM-MSCs) sorted from naive C57BL/6 mice were cultured for 10 days in control medium, osteogenic medium, or osteogenic medium plus mouse OSM (25 ng/ml). Quantification of Alizarin Red S staining via absorbance at 562 nm confirmed enhanced calcium deposition in interstitial cells (***P < 0.01), satellite cells (*P < 0.05), and BM-MSCs (****P < 0.001) in the presence of osteogenic media alone and significantly enhanced calcium deposition in both interstitial cells and satellite cells in the presence of osteogenic media plus OSM (****P < 0.001). Results are the mean and SDs of 2 separate experiments (n = 3 control media and n = 3–6 osteogenic media ± OSM/each experiment).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts